Extrapulmonary neuroendocrine cancer
Clinical trials for Extrapulmonary neuroendocrine cancer explained in plain language.
Never miss a new study
Get alerted when new Extrapulmonary neuroendocrine cancer trials appear
Sign up with your email to follow new studies for Extrapulmonary neuroendocrine cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Antibody-Like drug could boost chemo for rare cancer
Disease control Recruiting nowThis Phase 3 trial tests whether adding obrixtamig to standard chemotherapy helps people with advanced extrapulmonary neuroendocrine cancer live longer. About 390 adults will be randomly assigned to get either the combo or chemo alone. Obrixtamig is designed to help the immune sy…
Matched conditions: EXTRAPULMONARY NEUROENDOCRINE CANCER
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New scan could spot hidden cancers better than current methods
Diagnosis Recruiting nowThis study tests whether a new imaging agent called [18F]FAPI-74 can find certain cancers as well as or better than the standard PET tracer. About 320 adults with one of 11 cancer types (including pancreatic, liver, ovarian, and lung cancers) will receive both tracers and have th…
Matched conditions: EXTRAPULMONARY NEUROENDOCRINE CANCER
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC